| Eli Ipp, MD | |
|
21840 Normandie Ave, Ste. 700, Torrance, CA 90502-2047 | |
| (310) 222-5101 | |
| (310) 320-5463 |
| Full Name | Eli Ipp |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 21840 Normandie Ave, Torrance, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134182629 | NPI | - | NPPES |
| 00C417300 | Medicaid | CA | |
| M050376 | Other | CA | GROUP |
| DA6447 | Other | CA | RAILROAD MEDICARE |
| CH1382 | Other | CA | RAILROAD MEDICARE |
| W1494D | Other | CO | GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | C41730 (California) | Primary |
| Entity Name | County Of Los Angeles |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851363188 PECOS PAC ID: 1850296534 Enrollment ID: O20031204001218 |
News Archive
Easing phantom limb pain can be as simple as looking in the mirror. Scientists who have mapped how mirror therapy changes the brain may now be able to predict just how much treatment will ease a particular patient's pain.
Sandia National Laboratories is seeking commercial partners to license or contribute to the continued development of a new lab-on-a-chip platform for high-throughput manipulation and interrogation of individual cells, one that enables quantitative analysis of cellular behaviors with unprecedented speed, resolution, sensitivity, and multiplexing.
Some human embryonic stem cell researchers recently have questioned whether methods used in a study published in the Aug. 24 edition of the journal Nature were sufficient to conclude that human embryonic stem cells could be created without destroying the embryo, the Wall Street Journal reports (Hamilton/Regalado, Wall Street Journal, 9/5).
Boston Scientific Corporation today announced that it has received U.S. Food and Drug Administration clearance for the two validated manufacturing changes affecting all of its cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators, and that it will immediately resume distribution of its COGNIS CRT-Ds and TELIGEN ICDs.
The University of Texas MD Anderson Cancer Center today was awarded $19.6 million from the Cancer Prevention and Research Institute of Texas (CPRIT) to support research, recruitment and prevention efforts.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eli Ipp, MD 21840 Normandie Ave, Ste. 700, Torrance, CA 90502-2047 Ph: (310) 222-5101 | Eli Ipp, MD 21840 Normandie Ave, Ste. 700, Torrance, CA 90502-2047 Ph: (310) 222-5101 |
News Archive
Easing phantom limb pain can be as simple as looking in the mirror. Scientists who have mapped how mirror therapy changes the brain may now be able to predict just how much treatment will ease a particular patient's pain.
Sandia National Laboratories is seeking commercial partners to license or contribute to the continued development of a new lab-on-a-chip platform for high-throughput manipulation and interrogation of individual cells, one that enables quantitative analysis of cellular behaviors with unprecedented speed, resolution, sensitivity, and multiplexing.
Some human embryonic stem cell researchers recently have questioned whether methods used in a study published in the Aug. 24 edition of the journal Nature were sufficient to conclude that human embryonic stem cells could be created without destroying the embryo, the Wall Street Journal reports (Hamilton/Regalado, Wall Street Journal, 9/5).
Boston Scientific Corporation today announced that it has received U.S. Food and Drug Administration clearance for the two validated manufacturing changes affecting all of its cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators, and that it will immediately resume distribution of its COGNIS CRT-Ds and TELIGEN ICDs.
The University of Texas MD Anderson Cancer Center today was awarded $19.6 million from the Cancer Prevention and Research Institute of Texas (CPRIT) to support research, recruitment and prevention efforts.
› Verified 1 days ago
Deborah Chon, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 100, Torrance, CA 90505 Phone: 310-542-6333 | |
Erika Joyce Kalash, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3565 Del Amo Blvd, Torrance, CA 90503 Phone: 310-214-0811 | |
Hosayn Khaleeli, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2245 Sepulveda Blvd, Torrance, CA 90501 Phone: 310-320-3204 Fax: 310-320-0919 | |
Mr. Anthony C Dike, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 20280 S Vermont Ave Ste 215, Torrance, CA 90502 Phone: 323-434-4626 Fax: 310-693-8082 | |
Paul J Brown, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3333 Skypark Dr, Torrance, CA 90505 Phone: 310-517-9006 | |
Dr. Philip W Chung, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2841 Lomita Blvd 215, Torrance, CA 90505 Phone: 310-379-2860 Fax: 310-325-1144 | |
Dr. Diane Jennifer Prager, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 300, Torrance, CA 90505 Phone: 310-325-8252 |